A. Heald

发表

Differentiation of central nervous system lesions in AIDS patients using positron emission tomography (PET)

J. Hoffman, J. Bartlett, H. Waskin, 1996, International journal of STD & AIDS.

Effect of protease inhibitors on the sense of taste.

S S Schiffman, S. Schiffman, J. Zervakis, 1999, Nutrition.

HIV Infection: Treatment Outcomes in Older and Younger Adults

K. Schmader, M. Wellons, J. Bartlett, 2002, Journal of the American Geriatrics Society.

Dapsone/pyrimethamine may prevent mycobacterial disease in immunosuppressed patients infected with the human immunodeficiency virus.

A. Lazzarin, M. Opravil, A. Heald, 1995, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Effect of the nucleoside analogs zidovudine, didanosine, stavudine, and lamivudine on the sense of taste.

S. Schiffman, J. Zervakis, A. Heald, 1999, Nutrition.

Discontinuation of Mycobacterium avium complex prophylaxis in patients with antiretroviral therapy-induced increases in CD4+ cell count. A randomized, double-blind, placebo-controlled trial. AIDS Clinical Trials Group 362 Study Team.

J. Currier, S. Koletar, H. Valdez, 2000, Annals of internal medicine.

Skin Test Reactivity and Cellular Immune Responses toMycobacterium avium Sensitin in AIDS Patients at Risk for Disseminated M. avium Infection

C. F. von Reyn, J. Currier, S. Koletar, 2001, Clinical Diagnostic Laboratory Immunology.

Effect of antimicrobial and anti-inflammatory medications on the sense of taste

S. Schiffman, J. Zervakis, B. G. Graham, 2000, Physiology & Behavior.

Pharmacokinetics of lamivudine in human immunodeficiency virus-infected patients with renal dysfunction

J. Bartlett, A. Heald, P. Hsyu, 1996, Antimicrobial agents and chemotherapy.

Clinical complications of HIV infection.

C. Hicks, A. Heald, 1997, Radiologic clinics of North America.

Needlestick injuries among resident physicians

D. Ransohoff, A. Heald, David F. Ransohoff, 1990, Journal of General Internal Medicine.

Protease inhibitors are associated with a slowed progression of HIV-related renal diseases.

L. Svetkey, J. Bartlett, L. Szczech, 2002, Clinical nephrology.

Oropharyngeal yeast flora and fluconazole resistance in HIV‐infected patientsreceiving long‐term continuous versus intermitent fluconazole therapy

J. Perfect, J. Bartlett, W. Schell, 1996, AIDS.

Discontinuation of Mycobacterium avium Complex Prophylaxis in Patients with Antiretroviral TherapyInduced Increases in CD4+ Cell Count

Paige L. Williams, J. Currier, S. Koletar, 2000, Annals of Internal Medicine.

Cold neutron prompt gamma-ray activation analysis at NIST — Recent developments

R. Lindstrom, A. Heald, R. Paul, 1997 .

Once-weekly administration of dapsone/pyrimethamine vs. aerosolized pentamidine as combined prophylaxis for Pneumocystis carinii pneumonia and toxoplasmic encephalitis in human immunodeficiency virus-infected patients.

B. Hirschel, A. Lazzarin, M. Opravil, 1995, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Treatment for cerebral toxoplasmosis protects against Pneumocystis carinii pneumonia in patients with AIDS. The Swiss HIV Cohort Study.

B. Hirschel, J. Chave, A. Heald, 1991, Annals of internal medicine.

Safety, Tolerability, and Clinical Outcomes after Intraarticular Injection of a Recombinant Adeno-associated Vector Containing a Tumor Necrosis Factor Antagonist Gene: Results of a Phase 1/2 Study

K. Dao, P. Mease, M. Maricic, 2010, The Journal of Rheumatology.

Association of plasma levels of human immunodeficiency virus type 1 RNA and oropharyngeal Candida colonization.

J. Perfect, G. Cox, A. Heald, 1999, The Journal of infectious diseases.

Taste and smell losses in HIV infected patients

S. Schiffman, J. Bartlett, B. G. Graham, 1995, Physiology & Behavior.

AVI-7288 for Marburg Virus in Nonhuman Primates and Humans.

P. Iversen, D. Swenson, S. Bavari, 2015, New England Journal of Medicine.

Repeated aerosolized AAV-CFTR for treatment of cystic fibrosis: a randomized placebo-controlled phase 2B trial.

Thomas Ferkol, Carlos Milla, Frank Accurso, 2007, Human gene therapy.

Phase I trial of intranasal and endobronchial administration of a recombinant adeno-associated virus serotype 2 (rAAV2)-CFTR vector in adult cystic fibrosis patients: a two-part clinical study.

Terence R Flotte, Suzanne Beck, T. Flotte, 2003, Human gene therapy.

A Single Phosphorodiamidate Morpholino Oligomer Targeting VP24 Protects Rhesus Monkeys against Lethal Ebola Virus Infection

P. Iversen, S. Bavari, S. Reid, 2015, mBio.

Delayed Time-to-Treatment of an Antisense Morpholino Oligomer Is Effective against Lethal Marburg Virus Infection in Cynomolgus Macaques

G. Palacios, P. Iversen, S. Bavari, 2016, PLoS neglected tropical diseases.

Repeated adeno-associated virus serotype 2 aerosol-mediated cystic fibrosis transmembrane regulator gene transfer to the lungs of patients with cystic fibrosis: a multicenter, double-blind, placebo-controlled trial.

J. Clancy, D. Waltz, B. Ramsey, 2004, Chest.

Safety and Pharmacokinetics of LHF-535, a Potential Treatment for Lassa Fever, in Healthy Adults

S. M. Amberg, K. Bedard, A. Heald, 2022, Antimicrobial agents and chemotherapy.

Safety and Pharmacokinetic Profiles of Phosphorodiamidate Morpholino Oligomers with Activity against Ebola Virus and Marburg Virus: Results of Two Single-Ascending-Dose Studies

P. Iversen, P. Sazani, E. Kaye, 2014, Antimicrobial Agents and Chemotherapy.

Characteristics of Individuals Infected With the Human Immunodeficiency Virus and Provider Interaction in the Predominantly Rural Southeast

T. Nguyen, A. Heald, KATHRYN WHETTEN-GOLDSTEIN, 2001, Southern medical journal.

A prospective study of discontinuing primary and secondary Pneumocystis carinii pneumonia prophylaxis after CD4 cell count increase to > 200 × 106/l

J. McCutchan, D. Finkelstein, J. Currier, 2001, AIDS.

Effects of antibiotic treatment in the subset of common-cold patients who have bacteria in nasopharyngeal secretions

R. Auckenthaler, B. Hirschel, L. Kaiser, 1996, The Lancet.

Local delivery of a recombinant adenoassociated vector containing a tumour necrosis factor α antagonist gene in inflammatory arthritis: a phase 1 dose-escalation safety and tolerability study

E. Keystone, P. Mease, K. Hobbs, 2008, Annals of the rheumatic diseases.

A multicenter phase II study of tgDCC‐E1A for the intratumoral treatment of patients with recurrent head and neck squamous cell carcinoma

M. Hung, D. Villaret, G. Yoo, 2002, Head & neck.

Taste and smell complaints in HIV‐infected patients

S. Schiffman, C. Pieper, A. Heald, 1998, AIDS.

Assessing Single Joints in Arthritis Clinical Trials

R. Moskowitz, H. Schumacher, P. Mease, 2009, The Journal of Rheumatology.

Assessing single joints in arthritis clinical trials.

M. Boers, B. Bresnihan, H. Schumacher, 2007, The Journal of rheumatology.

A phase 1 study to evaluate the safety and immunogenicity of a recombinant HIV type 1 subtype C adeno-associated virus vaccine.

Philip R. Johnson, S. Kochhar, J. van Lunzen, 2008, AIDS research and human retroviruses.

A phase 2 study to evaluate the safety and immunogenicity of a recombinant HIV type 1 vaccine based on adeno-associated virus.

Philip R. Johnson, P. Kaleebu, L. Bekker, 2010, AIDS research and human retroviruses.

Stroke in a patient with human immunodeficiency virus and syphilis treated with penicillin and antiretroviral therapy.

M. Golden, C. Marra, A. Heald, 2011, Sexually transmitted diseases.

Evaluation of exposure and health care worker response to nebulized administration of tgAAVCF to patients with cystic fibrosis.

M. Yost, J. Camp, P. Zeitlin, 2004, The Annals of occupational hygiene.

Fibrosis: A Multicenter, Double-Blind, Placebo-Controlled Trial Cystic Transmembrane Regulator Gene Transfer to the Lungs of Patients With Repeated Adeno-Associated Virus Serotype 2 Aerosol-Mediated Cystic Fibrosis

J. Clancy, D. Waltz, B. Ramsey, 2006 .

Adult bacterial nasopharyngitis

R. Auckenthaler, L. Kaiser, F. Borst, 1993, Journal of general internal medicine.

Background morbidity in HIV vaccine trial participants from various geographic regions as assessed by unsolicited adverse events

P. Kaleebu, S. Kochhar, J. van Lunzen, 2012, Human vaccines & immunotherapeutics.

Single-joint Outcome Measures: Preliminary Validation of Patient-reported Outcomes and Physical Examination

P. Mease, A. Heald, P. Anklesaria, 2010, The Journal of Rheumatology.

1092. Clinical Studies of Intra_Articular Administration of a Recombinant Adeno_Associated Vector Containing a TNF_α Antagonist Gene in Inflammatory Arthritis

A. Heald, P. Anklesaria, G. Pate, 2006 .

Safety, tolerability, and pharmacokinetics of radavirsen (AVI‐7100), an antisense oligonucleotide targeting influenza a M1/M2 translation

R. Davey, P. Iversen, J. Beigel, 2018, British journal of clinical pharmacology.

Taste and smell. Neglected senses that contribute to the malnutrition of AIDS.

S. Schiffman, A. Heald, 1997, North Carolina medical journal.

Stroke in a patient with human immunodeficiency virus and syphilis treated with penicillin and antiretroviral therapy.

M. Golden, C. Marra, A. Heald, 2011, Sexually Transmitted Diseases.

Safety and Pharmacokinetic Profiles of Phosphorodiamidate Morpholino Oligomers with Activity against Ebola Virus and Marburg Virus: Results of Two Single-Ascending-Dose Studies

P. Iversen, P. Sazani, E. Kaye, 2014, Antimicrobial Agents and Chemotherapy.